Navigation Links
PhRMA Statement Supporting Fair Incentives for Biologics Innovation
Date:10/19/2009

age-associated infirmities ... [A] well-defined process for approving biosimilars will help sustain investment in this vital area of therapy development and allow for these treatments to one day be made widely available to patients who otherwise could not have access to them.' -- Alliance for Aging Research

"Creating a new biologic medicine is a complex, long-term endeavor that is costly, takes years of research, and has an uncertain chance of success. Development costs for innovative biologics alone can exceed $1.2 billion, plus up to an additional $450 million to build specialized manufacturing facilities.

"Already, many biotechnology companies that are the birthplace for many cutting-edge therapies face a bleak outlook. The recent financial crisis, for some, represented a deadly blow. Twenty-two biotechs have already been delisted from NASDAQ. This week, NVCA and Thomson Reuters reported that venture capital funds raised in the third quarter of 2009 plummeted to the lowest level in 15 years.

"R&D is the engine that drives continued medical advances that save lives and improve patients' quality of life, but few would tackle biologic medicines without a fighting chance to recoup their significant investments.

"Importantly, if we're going to cure cancer in our lifetime, as President Obama has challenged America to do, new innovative biologics, undoubtedly, will play an instrumental role."

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PhRMA Statement on Senate Finance Committee Vote
2. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
3. SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine
4. EAU Position Statement on Screening for Prostate Cancer
5. Joint Statement from the American Diabetes Association and American Association of Clinical Endocrinologists on the NICE-SUGAR Study on Intensive Versus Conventional Glucose Control in Critically Ill Patients
6. A Joint Statement From Americas Prostate Cancer Advocacy, Education, and Support Organizations
7. Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients
8. American Heart Association Scientific Statement: Heart Patients Should Be Screened, Treated for Depression
9. Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm
10. VA Statement on Smoking Cessation Research Program
11. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... BOULDER, Colo. , Nov. 25, 2014 ... ARRY ) today announced that its Chief ... speak at the following upcoming conferences.  The ... conferences through webcasts on the Array BioPharma ... ConferenceDate:Wednesday, December 3, 2014Time:1:30 p.m.  Eastern Time ...
(Date:11/26/2014)... 25, 2014 Halozyme Therapeutics, Inc. (NASDAQ: ... Conference in New York on Wednesday, ... Dr. Helen Torley , President and Chief Executive ... will be webcast through the "Investors" section of Halozyme,s corporate ... made available for 90 days following the event. To access ...
(Date:11/24/2014)... Juno Therapeutics today announced that the ... company,s JCAR015 chimeric antigen receptor product candidate.  The ... refractory B-cell acute lymphoblastic leukemia and was filed ... Center, where Phase 1 clinical trials are currently ... important news for patients who may benefit from ...
Breaking Medicine Technology:Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 2Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 3
(Date:11/26/2014)... 26, 2014 With Thousand Oaks cosmetic ... the prosthodontists at the Anacapa Dental Art Institute in Woodland ... can be daunting for some. , That is why they ... they offer. , “No dentist wants cost to come between ... teeth,” said Dr. Mamaly Reshad, partner in the Anacapa Dental ...
(Date:11/26/2014)... ISI Telemanagement Solutions, Inc., a ... award the 2014 Lync Pioneer Award ... as a great honor to ISI, who continues ... Specifically, ISI offers an integrated collaboration reporting and ... including voice, video, Lync IM, and conferencing. ...
(Date:11/26/2014)... 2014 Bunion Bootie, the newest and ... an early celebration of the early holiday shopping season. ... at the promotional price of $29.95 each (normally $33.95 ... to any automatic discounts applied when buying more than ... for complete details. It’s simple: purchasing more Bunion ...
(Date:11/26/2014)... Sonoran Vein and Endovascular nurse, ... Distinguished Preceptorship Award from The American Association ... the advancement of nurse practitioners. The Distinguished Preceptorship ... had made a significant contribution toward increasing the ... of Nurse Practitioners (AANP) is the largest full-service ...
(Date:11/26/2014)... -- Teens prescribed anti-anxiety or sleep medications are ... other teens, a new study warns. The ... assessments on teenagers before prescribing these drugs to ... don,t realize the abuse potential," said lead researcher ... Michigan School of Nursing. "These drugs produce highly ...
Breaking Medicine News(10 mins):Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 2Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 3Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 4Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 5Health News:ISI Telemanagement Solutions, Inc. has been Awarded the 2014 Microsoft Lync Pioneer Award 2Health News:Bunion Bootie Temporarily Lowering Prices for Holiday Shopping, Starting Today! 2Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2
... -- How children respond to the smell of alcoholic ... according to a new study from the Monell Chemical ... of beer and an unpleasant odor, children of mothers ... of Non-escape drinkers to choose the unpleasant odor. , ...
... 2007 State policies have a significant impact on ... could play a key role in efforts to expand ... study in the June issue of the Journal ... are uniquely positioned to institute specific policy proscriptions emanating ...
... perform most, but safety an issue in poorer areas, ... About 234 million major surgeries are performed worldwide each ... countries than in low-income countries, U.S. researchers report. , ... Health, and his colleagues defined major surgeries as any ...
... ANN ARBOR, Mich., June 25 HealthMedia(R), Inc.,s,Succeed(TM) ... Products (HIP) Certification from the National Committee for,Quality ... about,health care quality. As a result, health plans ... for using the Succeed,HRA, since responsibility for adherence ...
... of the ACL TOP Family -, LEXINGTON, Mass., June ... FDA clearance 510(k) for the ACL,TOP software V3.0.0. This clearance ... System in the United States as a member of the ... as the other members of the ACL,TOP Family, including the ...
... Dr. Hilton Becker M.D.,F.A.C.S., F.R.C.S. of Boca Raton, Florida, ... 20 years, has created his most effective,implant yet -- the ... adjust in both shape and size after it has been ... are disappointed with,the shape and size of the breast after ...
Cached Medicine News:Health News:Kids connect alcohol odors with mom's emotions 2Health News:State policies influence drug treatment programs 2Health News:Worldwide Surgery Rates Tied to Economic Status 2Health News:HealthMedia Health Risk Assessment Earns Prestigious NCQA Certification 2Health News:Instrumentation Laboratory Launches ACL Top(R) 500 CTS Hemostasis Testing System 2Health News:Boca Raton Based Plastic Surgeon Introduces Revolutionary New Adjustable Breast Implant to Europe and Asia 2
Intended for the quantitative determination of gammaglutamyl transferase activity in serum or plasma. Single vial, dry powder reagent. Readily soluble at room temperature. Reaction: Kinetic. Waveleng...
Intended for the quantitative determination of calcium in serum. Endpoint Reaction. Reaction complete within one minute, color developed is stable for 30 minutes. Wavelength: 570 nm. Linearity: 16 mg...
For the quantitative determination of alanine aminotransferase in serum used in routine examination and monitoring of therapy and relapses....
For the quantitative determination of Alanine Aminotransferase in serum. Optimized IFCC without P-5'-P, Linearity: 500 IU/L at 37 C. Liquid Working Reagent prepared with simple 1:9 dilution....
Medicine Products: